Cerecor Inc (CERC)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.93 -0.05 (-1.68%) 08/25/21 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.93 unch (unch) -
for Wed, Aug 25th, 2021
Results
download Want to compare other data? Select Fields| Symbol | CERC | ARCT | PHAT | ||
| Company | Cerecor Inc | Arcturus Therapeutics Ltd | Phathom Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.98 | 10.30 | 4.30 | ||
| High | 2.98 | 10.66 | 4.30 | ||
| Low | 2.90 | 10.11 | 4.02 | ||
| Last | 2.93 | 10.53 | 4.03 | ||
| Change | -0.05 | +0.23 | -0.19 | ||
| % Change | -1.68% | +2.23% | -4.62% | ||
| Volume | 268,000 | 358,100 | 956,100 | ||
| 20-Day Average Volume | 482,550 | 462,840 | 1,245,370 | ||
| Previous Close | 2.98 | 10.30 | 4.22 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.82 | 10.59 | 5.29 | ||
| 20-Day Raw Stochastic | 65.31% | 46.37% | 7.14% | ||
| 20-Day Relative Strength | 50.54% | 41.14% | 39.71% | ||
| Weighted Alpha | +4.80 | -65.30 | -56.06 | ||
| Today's Opinion | 40% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 8% Sell | 100% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.40% since 08/18/21 | +12.62% since 04/10/25 | -1.95% since 04/10/25 | ||
| Low | 2.61 on 08/19/21 | 9.22 on 04/11/25 | 4.02 on 04/17/25 | ||
| High | 3.00 on 08/24/21 | 11.00 on 04/15/25 | 5.09 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | +2.81% since 07/23/21 | -25.64% since 03/17/25 | -16.74% since 03/17/25 | ||
| Low | 2.51 on 07/27/21 | 8.04 on 04/07/25 | 3.81 on 04/10/25 | ||
| High | 3.10 on 08/10/21 | 14.37 on 03/18/25 | 6.89 on 03/28/25 | ||
| 3-Month | |||||
| %Chg | +13.13% since 05/25/21 | -37.28% since 01/17/25 | -42.10% since 01/17/25 | ||
| Low | 2.51 on 07/27/21 | 8.04 on 04/07/25 | 3.81 on 04/10/25 | ||
| High | 3.70 on 06/18/21 | 19.25 on 02/18/25 | 7.25 on 01/24/25 | ||
| 6-Month | |||||
| %Chg | -19.51% since 02/25/21 | -48.88% since 10/17/24 | -75.18% since 10/17/24 | ||
| Low | 2.06 on 05/13/21 | 8.04 on 04/07/25 | 3.81 on 04/10/25 | ||
| High | 4.15 on 03/02/21 | 21.61 on 11/11/24 | 19.50 on 11/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 281,306 | 285,574 | 280,637 | ||
| Shares Outstanding, K | 96,009 | 27,120 | 69,637 | ||
| Annual Sales | 6,700,000 | 152,310,000 | 55,250,000 | ||
| Annual Net Income | -63,500,000 | -80,940,000 | -334,330,000 | ||
| Last Quarter Sales | 3,360,000 | 22,770,000 | 29,660,000 | ||
| Last Quarter Net Income | -17,110,000 | -30,010,000 | -74,450,000 | ||
| 60-Month Beta | 1.44 | 3.41 | 0.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.11 on 03/06/25 | -0.79 on 03/06/25 | ||
| Latest Earnings Date | 08/05/21 | 05/14/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | 01/04/13 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||